packagePamiparib

pamiparib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pamiparib is an investigational anticancer drug belonging to the PARP inhibitor class. It is still under investigation and is not an approved medicine in the European Union or elsewhere.

Summary written by glm-5.3-flash from Wikidata Q125351134 and the WHO ATC classification; not checked by a person.

name:pamiparib
ATC codes:L01XK06
DrugBank:DB14769
PubChem CID:135565554
Wikidata:Q125351134
formula:C16H15FN4O
molar mass:298.321 g/mol (PubChem CID 135565554)
logP:1.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown